Dr Xavier Ding (FIND) Next Generation Plasmodium vivax diagnostics - TPP's
Dr Xavier Ding (FIND) discusses the challenges and hurdles in terms of defining next generation Plasmodium vivax diagnostics -for control an
Dr. Fiona Allen (NHM) Monitoring Schistosomiasis transmission using snail intermediate hosts
Dr. Fiona Allen (Natural History Museum) Monitoring Schistosomiasis transmission using snail intermediate hosts
Dr William de Glanville ( Uni of Liverpool) Diagnostics challenges for the NZD's
Dr William de Glanville ( Uni of Liverpool) Diagnostics challenges for the Neglected Zoonotic Diseases
Recorded at ISNTD D3 2017 May 17th a
Jim Mulry (Merck Global Health Institute): Diagnostic Update, Malaria & Schistosomiasis
At ISNTD d³ 2017, Dr. Jim Mulry, Head of Diagnostics at the Merck Global Health Initiative, speaks about current projects, tools and solutio
Dr Harriet Glindon (i-Sense) Mobile -connected diagnostic devices & engineering partnerships
Dr Harriet Glindon (i-Sense) Developing mobile -connected diagnostic devices through engineering partnerships
Recorded at ISNTD D3 May 17th
Prf. Rosanna Peeling (LSHTM) Future of Diagnostics for NTDs
At ISNTD d³ 2017 , Prf. Rosanna Peeling (LSHTM) Future of Diagnostics for NTDs ……………………………………………………. For more information please contact:...
Dr. Bonnie Webster (Natural History Museum London): Molecular diagnostics for schistosomiasis
At ISNTD d³ 2017, Dr. Bonnie Webster from the Natural History Museum London speaks about recent research at the NHM to develop molecular dia
Dr. Valerie Oriol Mathieu (Janssen Vaccines & Prevention): Ebola & Filoviruses Vaccine Devel
At ISNTD d³ 2017, Dr. Valerie Oriol Mathieu, Global Medical Affairs Lead at Janssen Vaccines & Prevention, speaks about current challeng
Infectious Thoughts Interview: Enwono Eyoh (University of Edinburgh)
Enwono Eyoh speaks to the ISNTD about current research at the University of Edinburgh's Parasite Immuno-epidemiology group on a vaccine
Infectious Thoughts Interview: Dr. Benny Baeten (Johnson & Johnson)
Dr. Benny Baeten, Compound Development Team Leader for Anthelmintics at the Janssen Pharmaceutical Companies of Johnson & Johnson speaks
